• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Molecular analysis of X-linked agammaglobulinemia (XLA) and Bruton's tyrosine kinase (Btk)

Research Project

Project/Area Number 09670154
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionOsaka University

Principal Investigator

TSUKADA Satoshi  Osaka University Medical School, Assistant Professor, 医学部, 助手 (60273637)

Co-Investigator(Kenkyū-buntansha) HASHIMOTO Shoji  Osaka University Hospital, Medical staff, 医学部・付属病院, 医員
Project Period (FY) 1997 – 1998
Keywordsagammaglobulinemia / Bruton's tyrosine kinase / Sab / immunodeficiency
Research Abstract

X-linked agammaglobulinemia (XLA), one of the most popular hereditary immunodeficiencies, exhibits the typical B-limphocyte deficiency characterized by a complete absence of humoral immunity.The dificient gene product in XLA is known as Btuon's tyrosine kinase (Btk).We have been investigating the pathogenisis of XLA from both clinical and molecular aspects.
1. We analized the function of the Btk-binding protein Sab (SH3-domain binding protein which preferentially associates with Btk), which we previously reported as a newly-identified SH3 domain-binding protein.Sab was shown to inhibit the auto- and transphosphorylahion activity of Btk, which prompted us to propose that Sab functions as a transregulator of Btk.Forced overexpression of Sab in B cells led to the reduction of BCR-induced tyrosine phosphorylation of Btk and significantly reduced the B cell antigen receptor-mediated early and late events including calcium mobilization, inositol 1, 4, 5-triphosphate production as well as apoptotic cell death in which the involvment of Btk activity has been previously shown.These results indicate the negative regulatory role of Sab in the B cell cytoplasmic tyrosine kinase pathway.
2. To understand the Btk signaling pathway, we have further searched the molecules which interact with Btk.We identified that one of the major Btk-SH2 domain binding proteins in B cells is BLNK (B cell linker protein) and present evidences that the interaction of BLNK and the SH2 domain of Btk contributes to the complete-tyrosine phosphorylation of phospholipase Cgamma, which leads the B cell antigen receptor-coupled clacium signaling to open.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Tsukada,S.: "Immunological disease(Bruton's agammaglobulinemia)." Internal Medicine. 36. 148-150 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Futatani,T.: "Flowcytometric detection of Bruton's tyrosine kinase defieicncy and its carrier in X linked agammaglobulinemia." Blood. 91. 595-602 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsushita,M.: "Identification and characterization of a novel SH3-domain binding protein,Sab,which preferentially associates with Bruton's tyrosine kinase(Btk)." Biochem.Biophys.Res.Commun.245. 337-343 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nonoyama,S.: "Functional analysis of the peripheral B cells in patients with X-linked agammaglobulinemia." J.Immunol.161. 3925-3929 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Baba,Y.: "WASP is involved in the tyrosine kinase pathway in B-lincage cells." Blood. 93. 2003-2012 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hashimoto,S.: "Atypical X-linked agammaglobulinemia(XLA)patients diagnosed in their adult ages." Internal Medicine. (in press). (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tsukada, S.: "Immunological disease (Bruton's agammaglobulinemia)." Internal Medicine. 36. 148-150 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Futatani, T., Tsukada, S., Hashimoto, S., Matsushita, M., Yamadori, T., Niida, Y., Kunikata, T., Arai, . S., Kurimoto, M., Imamura, H., Kishimoto, T., and Miyawaki, T.: "Flowcytometric detection of Bruton's tyrosine kinase deficiency and its carrier in X linked agammaglobulinemia." Blood. 91. 595-602 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsushita, M., Yamadori, T., Kato, S., Takemoto, Y., Inazawa, J., Baba, Y., Hashimoto, S., Sekine, S., Arai, S., Kunikata, T., Kurimoto, M., Kishimoto, T.and Tsukada, S.: "Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (Btk)." Biochem.Biophys.Res.Commun.245. 337-343 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nonoyama, S., Tsukada, S., Yamadori, T., Miyawaki, T., Jin, Y.Z., Watanabe, C., Morio, T., Yata, J-1.and Ochs, H.D.: "Functional analysis of the peripheral B cells in patients with X-linked agammaglobulinemia." J.Immunol.161. 3925-3929 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hashimoto, S., Miyawaki, T., Futatani, T., Kanegane, H., Usui, K., Nukiwa, T., Namiuchi, S., Matsushita, M., Yamadori, T., Suemura, M., Kishimoto, T.and Tsukada, S.: "A typical X-linked agammaglobulinemia (XLA) patients diagnosed in their adult ages." Internal Medicine. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Baba, Y., Nonoyama, S., Matsushita, M., Yamadori, T., Hashimoto, S., Imai, K., Arai, S., Kunikata, T., Kurimoto, M., Kurosaki, T., Ochs, H.D., Yata, J-I., Kishimoto, T.and Tsukada, S.: "WASP is involved in the tyrosine kinase pathway in B-lineage cells." Blood.93. 2003-2012 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maeda, A., Scharenberg, A.W., Tsukada, S., Bolen, J.B., Kinet, J-P.and Kurosaki, T.: "Paired Immunoglobulin-like receptor B (PIR-B)inhibits BCR-induced activation of Syk and Btk by SHP-1." Oncogene.(in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi